CCBR – SYNARC, the world’s leading provider of centralized imaging, molecular marker analyses and multinational clinical research facilities to the pharmaceutical and biotechnology industry, announced today a major change in its capital structure, led by a Group of Danish investors, including Nordic Bioscience A/S and Den Danske Forskningsfond.
